Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Left untreated, malignant pleural mesothelioma (MPM) is associated with uniformly poor prognosis. Better survival has been reported with surgery-based multimodality therapy, but to date, no trial has demonstrated survival benefit of surgery over other therapies. We evaluated whether cancer-directed surgery influenced survival independently from other predictors in a large population-based dataset. METHODS: The SEER database was explored from 1973 to 2009 to identify all cases of pathologically-proven MPM. Age, sex, race, year of diagnosis, histology stage, cancer-directed surgery, radiation, and vital status were analyzed. The association between prognostic factors and survival was estimated using Cox regression and propensity matched analysis. RESULTS: There were 14,228 patients with pathologic diagnosis of MPM. On multivariable analysis, female gender, younger age, early stage, and treatment with surgery were independent predictors of longer survival. In comparison to no treatment, surgery alone was associated with significant improvement in survival [adjusted hazard ratio (adj HR) 0.64 (0.61-0.67)], but not radiation [adj HR 1.15 (1.08-1.23)]. Surgery and radiation combined had similar survival as surgery alone [adj HR 0.69 (0.64-0.76)]. Results were similar when cases diagnosed between 1973 and 1999 were compared to cases diagnosed between 2000 and 2009. CONCLUSIONS: Despite developments in surgical and radiation techniques, the prognosis for MPM patients has not improved over the past 4 decades. Cancer-directed surgery is independently associated with better survival, suggesting that multimodal surgery-based therapy can benefit these patients. Further research in adjuvant treatment is necessary to improve prognosis in this challenging disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treasure, T., Lang-Lazdunski, L., Waller, D., Bliss, J. M., Tan, C., Entwisle, J., Snee, M., O'Brien, M., Thomas, G., Senan, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70149-8 · Cited by 708 · cited 1×
“A randomized controlled trial conducted in the UK to assess survival, complications, and quality of life after extra-pleural pneumonectomy [3] suggested that the extensive surgical approach did not offer any survival advantage over chemotherapy alone.”
BackgroundMesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival
Baumann, F., Flores, E., Napolitano, A., Kanodia, S., Taioli, E., Pass, H., Yang, H., & Carbone, M. (2015) · Carcinogenesis · doi:10.1093/carcin/bgu227 · Cited by 254
Self-citationPrice, B., & Ware, A. (2009) · Critical Reviews in Toxicology · doi:10.1080/10408440903044928 · Cited by 209
Taioli, E., Wolf, A. S., & Flores, R. M. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.09.056 · Cited by 191 · cited 1×
“A recent meta-analysis comparing survival after extra-pleural pneumonectomy and pleurectomy decortication [2] suggests that less invasive surgical approaches, such as pleurectomy/decortication are associated with prolonged survival.”
BackgroundSelf-citationBovolato, P., Casadio, C., Billè, A., Ardissone, F., Santambrogio, L., Ratto, G. B., Garofalo, G., Bedini, A. V., Garassino, M. C., Porcu, L., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000064 · Cited by 141 · cited 4×
“However, the improved survival with multi-modal therapy reported here confirms results of individual studies conducted in Europe [4] or in the US [5] on smaller series.”
BackgroundResultInfluentialCho, J., Feld, R., Leighl, N. B., Opitz, I., Anraku, M., Tsao, M., Hwang, D. M., Hope, A. J., & de Perrot, M. E. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000078 · Cited by 135 · cited 1×
“Radiation for MPM has been shown to be effective in trials conducted at specialized centers [7] suggesting that such approach should be conducted by experts in the field.”
BackgroundUpdated patterns of failure after multimodality therapy for malignant pleural mesothelioma
Baldini, E. H., Richards, W. G., Gill, R. R., Goodman, B. M., Winfrey, O. K., Eisen, H. M., Mak, R. H., Chen, A. B., Kozono, D., Bueno, R., et al. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.10.128 · Cited by 87 · cited 1×
“Kapeles et al [5]suggests that patients treated with trimodality therapy have a significantly improved survival, but the result is not confirmed by others [6].”
BackgroundFlores, R. M., Riedel, E., Donington, J. S., Alago, W., Ihekweazu, U. N., Krug, L. M., Rosenzweig, K. E., Adusumilli, P. S., Carbone, M., & Pass, H. I. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f1903e · Cited by 81 · cited 1×
“The present study follows a previously published SEER analysis from our group [8] on a smaller sample of patients (n = 5937), on the predictors of undergoing surgery.”
Self-citationCameron, R. B., Kotova, S., & Wong, R. M. H. (2015) · Cancer Management and Research · doi:10.2147/cmar.s72814 · Cited by 34
Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review.
Blomberg, C., Nilsson, J. A., Holgersson, G., Edlund, P., Bergqvist, M., Adwall, L., Ekman, S., Brattström, D., & Bergström, S. N. (2015) · PubMed · Cited by 27
Cited by
Kindler, H. L., Ismaila, N., Armato, S. G., Bueno, R., Hesdorffer, M., Jahan, T., Jones, C. M., Miettinen, M., Pass, H., Rimner, A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.6394 · Cited by 420
ERS/EACTS statement on the management of malignant pleural effusions
Bibby, A. C., Dorn, P., Psallidas, I., Porcel, J. M., Janssen, J., Froudarakis, M., Subotic, D., Astoul, P., Licht, P., Schmid, R., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00349-2018 · Cited by 316
Asbestos in High-Risk Communities: Public Health Implications
Emmett, E. A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041579 · Cited by 33
“[95] found no significant improvement in mean survival over the past four decades.”
Background
Metadata
- Authors
- Taioli, E., Wolf, A. S., Camacho-Rivera, M., Kaufman, A., Lee, D.-S., Nicastri, D., Rosenzweig, K., & Flores, R. M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-12-14
- Volume
- 10
- Issue
- 12
- Pages
- e0145039
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2219232761
- Cited by
- 158
- References
- 10
- FWCI
- 13.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.